Biogen Exec Says Co Expects Immunogenicity Data to Be Ready by October to Submit to FDA for Subcutaneous Leqembi Filing - Cantor Fitzgerald Conference
渤健公司高管表示,預計免疫原性數據將在十月準備就緒,可提交給FDA,用於Leqembi皮下注射的申請-康泰菲力士特會議
Biogen Exec Says Co Expects Immunogenicity Data to Be Ready by October to Submit to FDA for Subcutaneous Leqembi Filing - Cantor Fitzgerald Conference
渤健公司高管表示,預計免疫原性數據將在十月準備就緒,可提交給FDA,用於Leqembi皮下注射的申請-康泰菲力士特會議
譯文內容由第三人軟體翻譯。